Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-04-10

Clinical Trial Update: Daptomycin Versus Placebo in Patients With Neutropenia and Fever [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing daptomycin to placebo in patients with febrile neutropenia was terminated, and results were posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cubicin (daptomycin)

Snippet

Sponsor: University of Rochester | Conditions: Febrile Neutropenia | Phase 3 | Status: TERMINATED | Results posted: 2014-04-10